Categories: BrainHealthcareNews

The Siegel Rare Neuroimmune Association Creates First-Ever Online Micro-Course for People With Rare Neuroimmune Disorders

The online learning program reflects organization’s dedication to empowering individuals and families affected by these conditions with knowledge and support

POWELL, OH / ACCESSWIRE / June 20, 2024 / The Siegel Rare Neuroimmune Association (SRNA) has released several new courses as part of its unique online learning program. This innovative educational series provides a comprehensive understanding of rare neuroimmune disorders. Every course includes content developed with medical experts.

The program:

  • Improves knowledge and health literacy about rare neuroimmune disorders among individuals and/or their care partners impacted by these conditions.
  • Reduces uncertainty about the diagnoses by educating individuals about diagnostic tools and management.
  • Provides resources to help people have a meaningful discussion with their healthcare practitioner about their diagnosis and advocate for the best care.

The first course, “Understanding Rare Neuroimmune Disorders,” was released in February. Participants learn about the immune system, the nervous system, and the similarities and differences between each disorder.

Additional courses each focus on one condition – acute disseminated encephalomyelitis (ADEM), acute flaccid myelitis (AFM), MOG antibody disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), optic neuritis (ON), and transverse myelitis (TM). These in-depth courses answer questions including:

  • What is the disorder?
  • What symptoms are present at onset?
  • Who is most likely to be affected by the disorder?
  • How is the disorder acutely treated?
  • What is the prognosis for those living with the disorder?

Each course features videos with helpful animations, written text, and knowledge checks. The courses are accessible via screen reader for those who are blind or have low vision.

The courses are for SRNA members. Membership is free and opens the door to a wealth of information, support, and education.

Understanding rare neuroimmune disorders

In rare neuroimmune disorders, a person’s immune system mistakenly attacks the brain, spinal cord and/or optic nerves. These disorders have devastating lifelong impacts and often cause permanent complications like difficulty breathing, depression, vision loss, persistent pain, and paralysis. They can affect individuals of any age. People who are diagnosed have no warning this life-changing event will happen. These disorders can relapse so people may face this crisis multiple times. Progress has been made in diagnosing and treating these disorders, but no cure exists.

“We have learned from our community interactions that educating individuals impacted by rare neuroimmune disorders about the different diagnoses is key for better management and long-term care,” says Executive Director Chitra Krishnan.

This year is SRNA’s 30th anniversary, and SRNA encourages people to learn more about rare neuroimmune disorders and their lifelong impact. Visit the SRNA website and Facebook, LinkedIn and Instagram for 30th-anniversary education, advocacy events, and information.

# # #

The Siegel Rare Neuroimmune Association is a non-profit organization dedicated to the support of people with acute disseminated encephalomyelitis, acute flaccid myelitis, MOG antibody disease, neuromyelitis optica spectrum disorder, optic neuritis, and transverse myelitis. Our goal is to improve the quality of life of individuals with these rare neuroimmune disorders. Visit our website to learn more.

Contact Information

GG deFiebre, PhD
info@wearesrna.org
855-380-3330

SOURCE: Siegel Rare Neuroimmune Association

View the original press release on newswire.com.

View the original press release on accesswire.com

Staff

Recent Posts

Restart Life Receives Aggregate Gross Proceeds of Approximately $590,000 from Warrant Exercises and Loan

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

1 hour ago

FlyteHealth to Expand Direct Access to Obesity Management Medication for Employers

NEW CANAAN, Conn., Dec. 22, 2025 /PRNewswire/ -- FlyteHealth, a national leader in integrated cardio-kidney-metabolic care,…

1 hour ago

10 Days, 10 Ways to Spend FSA (Flexible Spending Account) Funds Before the December 31 Use-It-or-Lose-It Deadline, from FSA Store®

The clock is ticking on 2025 FSA funds, and as the use-it-or-lose-it deadline approaches, FSA…

1 hour ago

TraceLink Wins 2025 Merit Award — Recognized for Healthcare Innovation for the Third Consecutive Year

TraceLink has been named a winner of the 2025 Merit Awards for Healthcare Innovation, marking…

1 hour ago

NUCALM CELEBRATES RECORD-BREAKING DECEMBER WITH OVER 2 BILLION MINUTES USED AND LARGEST LIVE EVENT ACTIVATION EVER

Tony Robbins' "Date with Destiny" Event Drives Unprecedented Engagement with NuCalm TechnologyPALM BEACH, Fla., Dec.…

1 hour ago

Point-of-Care Is Just the Beginning: Doceree 360 Report Maps Three Strategic Imperatives for HCP Engagement Across All Digital Touchpoints

New Annual Report Reveals Opportunity for Pharma Marketers to Reach Physicians Throughout Entire Decision-Making Journey—From Learning…

1 hour ago